Cargando…
A multimodal iPSC platform for cystic fibrosis drug testing
Cystic fibrosis is a monogenic lung disease caused by dysfunction of the cystic fibrosis transmembrane conductance regulator anion channel, resulting in significant morbidity and mortality. The progress in elucidating the role of CFTR using established animal and cell-based models led to the recent...
Autores principales: | Berical, Andrew, Lee, Rhianna E., Lu, Junjie, Beermann, Mary Lou, Le Suer, Jake A., Mithal, Aditya, Thomas, Dylan, Ranallo, Nicole, Peasley, Megan, Stuffer, Alex, Bukis, Katherine, Seymour, Rebecca, Harrington, Jan, Coote, Kevin, Valley, Hillary, Hurley, Killian, McNally, Paul, Mostoslavsky, Gustavo, Mahoney, John, Randell, Scott H., Hawkins, Finn J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338271/ https://www.ncbi.nlm.nih.gov/pubmed/35906215 http://dx.doi.org/10.1038/s41467-022-31854-8 |
Ejemplares similares
-
Generation of mesenchyme free intestinal organoids from human induced pluripotent stem cells
por: Mithal, Aditya, et al.
Publicado: (2020) -
Challenges Facing Airway Epithelial Cell-Based Therapy for Cystic Fibrosis
por: Berical, Andrew, et al.
Publicado: (2019) -
Human iPSC-derived alveolar and airway epithelial cells can be cultured at air-liquid interface and express SARS-CoV-2 host factors
por: Abo, Kristine M., et al.
Publicado: (2020) -
MicroRNAs promote skeletal muscle differentiation of mesodermal iPSC-derived progenitors
por: Giacomazzi, Giorgia, et al.
Publicado: (2017) -
Banking on iPSC- Is it Doable and is it Worthwhile
por: Solomon, Susan, et al.
Publicado: (2014)